Study of Sivelestat Sodium in OPCABG
Recruiting
Phase 2
Interventional Study
Coronary Heart Disease
Coronary Artery Disease
Coronary Arterial Disease (CAD)
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 75
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 62 (estimated)
- Sponsor
- Affiliated Hospital of Nantong University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to learn if drug Sivelestat Sodium works to improve the prognosis of off-pump coronary artery bypass grafting (OPCABG) in adults. It will also learn about the safety of drug Sivelestat Sodium. The main questions it aims to answer are:
* Does drug Sivelestat Sodium have a protective effect on myocardial injury after OPCABG?
* Does Sivelestat Sodium exert a protec…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Undergoing elective OPCABG (≥2 bridged vessels). LVEF≥35%, no severe liver or kidney function abnormalities (ALT/AST≤3 times the upper limit, eGFR≥60 mL/min). Sign the informed consent form.
Exclusion Criteria:
* Emergency operation, combined valve surgery or aortic surgery.…
Contacts